30 closest matches · ranked by relevance
Weight
Primary: Weight — 3.2; 6.8; 7.0 percent weight lost — p=<0.05
Complications; Contraceptive · Female Lactation
Primary: Time to Lactogenesis Stage II — 64.3; 65.2 hours — p=<0.05
Adolescence · Contraception · Postpartum
Primary: Continuation at 1 Year — 21; 30 participants
Contraception
Primary: IUD Usage Rate at 6 Months — 43; 39 participants
Family Planning · Contraception · PostPartum
Primary: Number of Patients Who Receive Contraception by Two Months Postpartum — 474; 339 Participants — p=0.12
Postpartum Contraception · Family Planning
Primary: Time to Lactogenesis Stage II [Questionnaire] — 65; 67.5 hours
Contraception · Malposition of Intrauterine Contraceptive Device
Primary: Number of Participants Who Would Recommend the LNG-IUS to a Friend at 6-months Postpartum. — 40 Participants
Unplanned Pregnancy
Primary: IUD Expulsion — 11 Participants
Contraception · Postpartum Depression · Lactation
Primary: Duration of Breastfeeding Among Women Who Plan to Breastfeed Their Infants After Postpartum or Delayed (4-6 Weeks Postpartum) Initiation of DMPA — 71; 70; 4; 4…
Continuation Rate of Contraceptive Implant
Primary: Continuation Rate — 20; 18 participants
Contraception · Breastfeeding · Postpartum Contraception
Primary: Number of Participants Breastfeeding at 6 Months — 6; 4; 6 Participants
Contraception
Primary: Proportion of Participants With an IUD Expulsion (Complete) at 6 Months — 0; 3 Participants
Postpartum Contraception
Primary: Breastfeeding — 10; 9 participants
Breast Feeding · Contraception
Primary: Number of Participants Who Continued to Breastfeed at 6 Months — 15; 14; 8; 9 participants
Postpartum
Primary: Number of Participants With Implant Use at Three Months — 28; 2 Participants
Contraception · Breastfeeding
Primary: Exclusive Lactation Among Birthing People at 8 Weeks Postpartum. — 7; 7; 6 Participants
Contraception
Primary: IUD Expulsion Rate — 20; 7 Participants
Contraceptive Usage
Primary: Number of Participants With Contraceptive Implant Continuation at Six Months Postpartum — 15; 7 Participants
Postpartum Period
Primary: Mirena in Place — 10; 3 participants
Contraceptive Usage
Primary: Feasibility of Application — 4.47; 4.52; 4.16; 4.26 units on a scale
Intrauterine Devices · Cesarean Section
Primary: IUD Use — 32; 40 participants
Contraceptive Usage · Contraception Behavior
Primary: Total Counseling Time — 16.8; 16.3 minutes
Post Abortion Care
Primary: Contraceptive Acceptability and Use of Contraceptives During the 6-month Follow-up — 121; 86 participants
Contraception
Primary: Breastfeeding Continuation Rates at 8 Weeks Postpartum — 88; 86 Participants
Contraception
Primary: Continuation Rates — 82; 78; 83 participants
Tobacco Use Cessation · Tobacco Use Disorder
Primary: Number of Participants Who Relapsed by Week 4 Postpartum — 6; 7 participants
HPV-Related Malignancy
Primary: Patient Indication of Willingness to Accept the Vaccine Based on Survey — 56 Participants
Post Partum
Primary: ABILITY TO FOLLOW POSTPARTUM TEENS FOR 1 YEAR. — 22; 16 Participants
HIV-1-infection
Primary: Recent PrEP Adherence — 33; 18 Participants — p=<0.001
Postpartum Period
Primary: Bleeding Patterns — 15; 18; 13; 7 days